These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 24682745)

  • 61. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
    Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The association between histological subtype of a first primary endometrial cancer and second cancer risk.
    Rhoades J; Vetter MH; Fisher JL; Cohn DE; Salani R; Felix AS
    Int J Gynecol Cancer; 2019 Feb; 29(2):290-298. PubMed ID: 30718311
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80.
    Osterlind A; Olsen JH; Lynge E; Ewertz M
    Natl Cancer Inst Monogr; 1985 Dec; 68():361-88. PubMed ID: 4088310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Second neoplasms after invasive and borderline ovarian cancer.
    Levi F; Randimbison L; Blanc-Moya R; La Vecchia C
    Eur J Cancer Prev; 2009 Jun; 18(3):216-9. PubMed ID: 19491608
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001.
    Soerjomataram I; Louwman WJ; de Vries E; Lemmens VE; Klokman WJ; Coebergh JW
    Breast Cancer Res Treat; 2005 Sep; 93(1):91-5. PubMed ID: 16184464
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.
    Fung C; Fossa SD; Milano MT; Oldenburg J; Travis LB
    J Clin Oncol; 2013 Oct; 31(30):3807-14. PubMed ID: 24043737
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers.
    Adjei Boakye E; Wang M; Sharma A; Jenkins WD; Osazuwa-Peters N; Chen B; Lee M; Schootman M
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1765-1779. PubMed ID: 32356175
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
    Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
    PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Association of malignant brain tumors and cancers of other sites.
    Ahsan H; Neugut AI; Bruce JN
    J Clin Oncol; 1995 Dec; 13(12):2931-5. PubMed ID: 8523057
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis.
    Li Z; Wu Q; Song J; Zhang Y; Zhu S; Sun S
    Horm Cancer; 2018 Jun; 9(3):197-204. PubMed ID: 29556910
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
    Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Descriptive characteristics of prostate cancer in patients with a history of primary male breast cancer - a SEER analysis.
    Abhyankar N; Hoskins KF; Abern MR; Calip GS
    BMC Cancer; 2017 Sep; 17(1):659. PubMed ID: 28946846
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy.
    Chow JCH; Au KH; Mang OWK; Cheung KM; Ngan RKC
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):48-55. PubMed ID: 29932287
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Treatment-related secondary cancer in malignant meningiomas: a population-based study.
    Bao X; Cao L; Piao H; Xie L
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):583-8. PubMed ID: 24509624
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Risk of second primary cancers among survivors of gynecological cancers.
    Adjei Boakye E; Grubb L; Peterson CE; Osazuwa-Peters N; Grabosch S; Ladage HD; Huh WK
    Gynecol Oncol; 2020 Sep; 158(3):719-726. PubMed ID: 32616403
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe.
    Bright CJ; Hawkins MM; Winter DL; Alessi D; Allodji RS; Bagnasco F; Bárdi E; Bautz A; Byrne J; Feijen EAM; Fidler MM; Garwicz S; Grabow D; Gudmundsdottir T; Guha J; Haddy N; Jankovic M; Kaatsch P; Kaiser M; Kuehni CE; Linge H; Øfstaas H; Ronckers CM; Skinner R; Teepen JC; Terenziani M; Vu-Bezin G; Wesenberg F; Wiebe T; Sacerdote C; Jakab Z; Haupt R; Lähteenmäki P; Zaletel LZ; Kuonen R; Winther JF; de Vathaire F; Kremer LC; Hjorth L; Reulen RC;
    J Natl Cancer Inst; 2018 Jun; 110(6):649-660. PubMed ID: 29165710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.